{
    "Trade/Device Name(s)": [
        "LOCI CA 19-9 Flex Reagent Cartridge",
        "Dimension Vista LOCI 7 Calibrator"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "k100375",
    "Predicate Device Reference 510(k) Number(s)": [
        "k031393"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NIG",
        "JIT"
    ],
    "Summary Letter Date": "March 31, 2011",
    "Summary Letter Received Date": "April 1, 2011",
    "Submission Date": "February 11, 2010",
    "Regulation Number(s)": [
        "21CFR866.6010",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system",
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "CA 19-9 tumor-associated antigen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Homogeneous sandwich immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Dimension Vista LOCI CA 19-9 Flex Reagent Cartridge and LOCI 7 Calibrator for quantitative measurement and calibration of CA 19-9 tumor antigen in serum and plasma",
    "Indications for Use Summary": "CA 19-9 method aids in monitoring disease status of patients with confirmed exocrine pancreatic cancer by serial measurement of CA 19-9 in serum or plasma; LOCI 7 Calibrator calibrates the CA 19-9 method on the Dimension Vista System",
    "fda_folder": "Immunology"
}